New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches

Antiphospholipid Syndrome (APS) is an autoimmune disorder, characterized by pregnancy morbidity and/or a hyper coagulable state involving the venous or the arterial vasculature and associated with antiphospholipid antibodies (aPL), including anti-cardiolipin antibodies (aCL), anti-beta2-glycoprotein...

Full description

Bibliographic Details
Main Authors: Chary Lopez-Pedrera, Nuria Barbarroja, Alejandra Mª Patiño-Trives, Eduardo Collantes, Mª Angeles Aguirre, Carlos Perez-Sanchez
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Immunology
Subjects:
Antiphospholipid Syndrome
cardiovascular disease
genomics
microRNAs
therapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00764/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.00764/full

Similar Items